![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 16, 14186-14193, April 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§,
From the
Department of Biochemistry, Duke University
Medical Center, Durham, North Carolina 27710 and ¶ Middle
Atlantic Mass Spectrometry Laboratory, Department of Pharmacology and
Molecular Sciences, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21205-2185
Received for publication, January 14, 2002, and in revised form, February 4, 2002
| |
ABSTRACT |
|---|
|
|
|---|
An acyltransferase induced by cold shock in
Escherichia coli, designated LpxP, incorporates a
palmitoleoyl moiety into nascent lipid A in place of the secondary
laurate chain normally added by LpxL(HtrB) (Carty, S. M.,
Sreekumar, K. R., and Raetz, C. R. H. (1999)
J. Biol. Chem. 274, 9677-9685). To determine whether the palmitoleoyl residue alters the properties of the outer membrane and imparts physiological benefits at low growth temperatures, we
constructed a chromosomal insertion mutation in lpxP, the
structural gene for the transferase. Membranes from the
lpxP mutant MKV11 grown at 12 °C lacked the cold-induced
palmitoleoyltransferase present in membranes of cold-shocked wild type
cells but retained normal levels of the constitutive lauroyltransferase
encoded by lpxL. When examined by mass spectrometry, about
two-thirds of the lipid A molecules isolated from wild type E. coli grown at 12 °C contained palmitoleate in place of
laurate, whereas the lipid A of cold-adapted MKV11 contained only
laurate in amounts comparable with those seen in wild type cells grown
at 30 °C or above. To probe the integrity of the outer membrane,
MKV11 and an isogenic wild type strain were grown at 30 or 12 °C and
then tested for their susceptibility to antibiotics. MKV11 exhibited a
10-fold increase in sensitivity to rifampicin and vancomycin at
12 °C compared with wild type cells but showed identical resistance when grown at 30 °C. We suggest that the palmitoleoyltransferase may
confer a selective advantage upon E. coli cells growing at lower temperatures by making the outer membrane a more effective barrier to harmful chemicals.
A unique glycolipid known as lipopolysaccharide is the major
component of the outer surface of the outer membranes of Gram-negative bacteria and forms a barrier around the cell (1-3). Compounds with
molecular weights of less than 600 penetrate the outer membrane via
porins, but larger, potentially harmful agents, including many
antibiotics, are excluded (2). Lipid A is the hydrophobic anchor of the
lipopolysaccharide molecule (1, 4-6). In wild type Escherichia
coli grown at 30 °C or above, lipid A consists of a
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
,1'-6-linked disaccharide of glucosamine that is phosphorylated at
the 1- and 4'-positions (Fig. 1) (1,
4-6). E. coli lipid A usually contains six acyl chains (1,
4). (R)-3-Hydroxymyristoyl groups are located at positions
2, 3, 2', and 3' of the glucosamine disaccharide, and two short
saturated acyl chains are attached to the
(R)-3-hydroxymyristoyl groups of the distal unit, forming acyloxyacyl moieties (Fig. 1, "Normal" lipid A)
(1, 4-6). Laurate is linked to the (R)-3-hydroxymyristoyl
residue at position 2', and myristate is similarly attached at position
3' (1, 4-6). These so-called "secondary" acyl chains are the same
in wild type E. coli and Salmonella.

View larger version (22K):
[in a new window]
Fig. 1.
Biosynthesis of Kdo2-lipid
A during cold shock. In cells grown at 30 °C or above, the key
precursor Kdo2-lipid IVA is utilized solely by
the lauroyltransferase (8), LpxL. However, in cold-shocked cells, an
additional acyltransferase, designated LpxP (15), is induced, which is
proposed to incorporate palmitoleate at the same site normally reserved
for laurate. In wild type cells, the action of LpxL and LpxP is
followed rapidly by the myristoyltransferase, LpxM, generating
hexa-acylated lipid A (7, 9). About two-thirds of the hexa-acylated
lipid A isolated from cells grown overnight at 12 °C contains
palmitoleate, and the remainder contains laurate. When the PhoP/PhoQ
system is activated or when cells are grown on ammonium metavanadate, a
portion of the lipid A molecules contain a palmitate residue at
position 2, which is incorporated by the outer membrane enzyme PagP
using glycerophospholipids as palmitate donors (37).
Two inner membrane enzymes, LpxL(HtrB) and LpxM(MsbB), which act late in the lipid A pathway (Fig. 1), are responsible for the incorporation of laurate and myristate, respectively (7-9). These enzymes require the presence of a 3-deoxy-D-manno-octulosonic acid (Kdo)1 disaccharide in their acceptor substrates (Fig. 1) (7-9). E. coli mutants lacking LpxM grow at nearly normal rates (10) and contain penta-acylated lipid A species lacking myristate (9, 11). However, cells lacking LpxM are ~10,000-fold less potent in activating human macrophages than wild type E. coli (12). Mutants defective in LpxL or in both LpxL and LpxM do not grow above 32 °C on rich medium (10, 13), show increased sensitivity to antibiotics (14), and accumulate tetra-acylated lipid A moieties in their inner membranes at 42 °C concomitant with cessation of growth (11).
Recently, a cold shock-induced enzyme that catalyzes the transfer of a palmitoleoyl chain from palmitoleoyl-acyl carrier protein to the lipid A precursor Kdo2-lipid IVA was discovered in our laboratory (15). The greater similarity of the palmitoleoyltransferase (LpxP) to the lauroyltransferase (LpxL) than to the myristoyltransferase (LpxM), and the ability of LpxP to use the same Kdo2-lipid IVA substrate as LpxL (Fig. 1), led us to suggest that LpxP acylates the 2' (R)-3-hydroxymyristoyl chain (15). LpxP activity is induced within 15 min following a shift of exponentially growing cells from 37 to 12 °C and peaks after 2 h (15). Appearance of palmitoleoyltransferase activity is correlated with massive accumulation of lpxP mRNA at 12 °C (15).
Modification of bacterial cell membranes in response to cold shock is
not unprecedented (16, 17). Following exposure to low temperatures,
some Gram-positive bacteria, like Bacillus subtilis, produce
a fatty acid desaturase encoded by des, resulting in
production of glycerophospholipids with unsaturated acyl chains in
addition to the branched chains normally present in Gram-positive
bacteria (17, 18). The fatty acids of E. coli
glycerophospholipids contain some unsaturated acyl chains at all growth
temperatures (19), but their composition shifts toward greater
unsaturation during cold shock because of increased
-ketoacyl-ACP
synthase II (FabF) activity (16). Additional acyltransferases that
selectively incorporate unsaturated fatty acyl chains into
glycerophospholipid are not induced by cold shock in E. coli
(16). The constitutive glycerol-3-phosphate acyltransferases of
E. coli utilize whatever acyl donors are most abundant in
the acyl-ACP and acyl-coenzyme A pools (20-22). LpxP is the first
example of a specific acyltransferase that is induced by cold shock
(15).
The incorporation of an unsaturated fatty acyl chain into lipid A might
alter the physical properties of the outer membrane to benefit the cell
in cold environments. We have therefore constructed the strain MKV11
with an insertion mutation in the palmitoleoyltransferase structural
gene, lpxP. MKV11 lacks detectable cold shock-induced LpxP
activity in vitro but retains the constitutive
lauroyltransferase (Fig. 1). Palmitoleate-containing species are absent
in lipid A isolated from the mutant subjected to cold shock, whereas
two-thirds of the lipid A from cold-shocked wild type E. coli contain palmitoleate. Although our lpxP mutant
strain exhibits no obvious growth defects at 12 °C, the integrity of
its outer membrane is compromised. Minimal inhibitory concentrations
for rifampicin and vancomycin are 10 times lower in MKV11 than wild
type cells at 12 °C but are the same at 30 °C. Genes encoding
cold-induced lipid A acyltransferases are present in many bacteria that
survive for long periods outside of animal hosts, including E. coli, all serovars of Salmonella enterica, and
Klebsiella pneumoniae, but are absent in pathogens transmitted from animal to animal.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials--
[
-32P]ATP was purchased from
PerkinElmer Life Sciences. Surfact-Amps grade Triton X-100 and the
bicinchoninic acid (BCA) protein determination kit were obtained from
Pierce. All restriction enzymes and the T4 DNA ligase were products of
New England Biolabs. Cloned Pfu DNA polymerase and the PCR
buffers were obtained from Stratagene. Primers and
isopropyl-thio-
-D-galactoside (IPTG) were purchased from
Invitrogen. Deoxyribonucleotides were purchased from Roche Molecular
Biochemicals. Sodium chloride, agarose, magnesium chloride, 88%
formic acid, and glass-backed Silica Gel 60 thin layer chromatography plates (0.25 mm) were from Merck. Pyridine was from Mallinckrodt Chemical Works. Tryptone, peptone, yeast extract, and other growth media agar were from Difco. All other materials were purchased from
Sigma unless otherwise mentioned.
Bacterial Strains and Growth Conditions-- Table I lists the E. coli K12 strains and the plasmids used in this study. Cells were cultured at the temperatures noted below in Luria broth (LB), consisting of 10 g of tryptone, 5 g of yeast extract, and 10 g of NaCl/liter (23). Antibiotics were added as necessary at the following concentrations: 30 µg/ml for kanamycin, 25 µg/ml for chloramphenicol, 25 µg/ml for tetracycline, 100 µg/ml for ampicillin, and 20 µg/ml for streptomycin.
Isolation of DNA for Molecular Biology Applications-- All plasmid DNA and DNA fragment isolations were performed following the protocols for the QIAprep® Spin Miniprep Kit and the QIAEX® II Gel Extraction Kit (Qiagen), respectively. Genomic DNA was isolated using the protocol for bacterial cultures in the Easy-DNATM kit (Invitrogen). Molecular biology protocols followed are those described by Sambrook et al. (24).
Construction of a Temperature-sensitive Plasmid Carrying an lpxP::kan Insertion-- Plasmid pUC4K (Table I) was digested with EaeI to extract the kanamycin resistance gene cassette. The reaction was analyzed by agarose gel electrophoresis, and the 1485-bp fragment containing the kan element was purified from the agarose. pSK57 was digested with NotI, which cuts the lpxP gene at position 417 (15, 25). The kan cassette was then ligated with T4 DNA ligase into pSK57 at this position using the compatible NotI and EaeI overhanging ends to create plasmid pSMC1. The lpxP::kan fragment was amplified from pSMC1 via PCR using primers to the 5' (5'-PGCGGGCCATATGTTTCCACAATGC-3') and 3' (5'-PGCGGGCCGAATTCAGGAGGGAAAGA-3') ends of lpxP. pMAK705, a vector with a gene for chloramphenicol resistance and a temperature-sensitive origin of replication, was digested with HincII, which yields blunt ends (26). The PCR product containing lpxP::kan was blunt-end ligated into this site, generating the plasmid pSMC2.
Creation of the lpxP::kan Insertion Mutant MKV11-- MKV11 (MC1061 lpxP::kan) was constructed according to published procedures (26, 27). pSMC2 was transformed into wild type MC1061 using 100 mM CaCl2 treatment, followed by heat shock (24). The selection for bacterial colonies containing pSMC2 was performed at 30 °C on LB plates containing chloramphenicol. After growth of a single colony to mid log phase in LB medium at 30 °C, selection for recombination of this plasmid into the chromosome was executed at 44 °C on LB agar containing chloramphenicol. After three cycles of growth at 30 °C to stationary phase with 100-fold back dilution of a colony containing an integrated plasmid, selection for a recombinant that had retained lpxP::kan on the chromosome and had transferred the intact lpxP gene to the temperature-sensitive covering plasmid was performed in the following manner. Single colonies were selected for resistance to chloramphenicol at 30 °C but not 44 °C by replica plating (27). Mutant MKV11, which was identified in this manner, subsequently was found to grow on LB broth in the presence or absence of kanamycin at 30 and 44 °C, indicating that the lpxP covering plasmid could be cured without loss of viability.
A polymerase chain reaction using primers specific to the 5' (5'-GCAACGGGCCATATGTTTCCACAATGCAAA-3') and 3' (5'-GCAGTCCTCGAGTTAAATGTACAACGACG-5') ends of lpxP was performed on genomic DNA isolated from the wild type and strain MKV11, as well as on the excised plasmid pMKV11, isolated from the mutant prior to curing at 44 °C. PCR products were run on a 1% agarose gel, and band sizes were compared with molecular weight standards. A band of ~1 kb, the size of the intact lpxP gene, was produced from the wild type genomic DNA and from the pMKV11 plasmid, verifying that the intact lpxP gene had been excised from the chromosome with the plasmid. However, a band of ~2.4 kb, the size of lpxP::kan, was produced from genomic DNA obtained from the mutant strain, MKV11, confirming that the lpxP gene was disrupted.
Growth Rate Comparisons-- Cultures of wild type and mutant strains were grown at 12 °C starting at an A600 of ~0.03. The A600 was measured every 6-8 h. For prolonged growth rate comparisons, cultures were diluted into fresh medium at regular intervals to maintain cell densities below A600 = 0.6.
Preparation of Substrates for Enzymatic Assays--
Carrier
(Kdo)2-lipid IVA was prepared by enzymatic
synthesis on a 5-10-mg scale starting with lipid IVA (28).
(Kdo)2-4'-32P-lipid IVA was made
from 4'-32P-lipid IVA by a scaled down version
of a similar enzymatic procedure (29) and was purified by thin layer
chromatography. Substrates were stored as aqueous dispersions at
20 °C. Lauroyl- and palmitoleoyl-acyl carrier proteins (ACP) were
synthesized from commercial ACP using recombinant E. coli
acyl-ACP synthase (30). Previous procedures (31) were modified by
including an additional purification step (an octyl-Sepharose column)
(32) to remove residual non-acylated ACP, which may be present at
higher amounts with unsaturated fatty acids because of the reduced
activity of acyl-ACP synthase with palmitoleate as the substrate
(33).
Cold Shock Conditions and Preparation of Membranes for Use in Enzyme Assays-- Shaking cultures (typically 100 ml) were grown on LB broth at 30 °C to A600 of ~0.4. The cultures were divided into two equal portions. One was incubated further at 30 °C for 2 more hours, and the other was shifted to 12 °C for 2 h. Cells were then harvested by centrifugation at 5000 × g in a Beckman JS4.3 swinging bucket rotor, washed in 10 ml of 30 mM Hepes, pH 7.5, centrifuged a second time, resuspended in 5 ml of Hepes buffer, and lysed by passage through a small French pressure cell at 10,000 pounds/square inch. Cell debris was removed by centrifugation at 4000 × g for 10 min, and the resulting cell-free extract was subjected to ultracentrifugation at 100,000 × g for 60 min in a Beckman Ti-70.1 rotor. The supernatant was decanted, and the membranes were homogenized in Hepes buffer. The sample was subjected to a second 60-min ultracentrifugation to remove residual soluble molecules and then resuspended in Hepes buffer to yield final protein concentrations of 1-5 mg/ml, as determined using the BCA assay (34).
Assay for Palmitoleoyltransferase Activity-- Assay mixtures (15 µl final volume), containing 50 mM Hepes, pH 7.5, 250 mM NaCl, 5 mM MgCl2, 0.1% Triton X-100, 6 µM (Kdo)2-4'-32P-lipid IVA (80,000 cpm/nmol) and 25.0 µM palmitoleoyl-ACP, as indicated, were preincubated at 12 °C for 10 min. Cell membranes, diluted in 30 mM Hepes, pH 7.5, as appropriate, were then added to give a final protein concentration of 0.1 mg/ml. The reactions were incubated at 12 °C for 8 h (15), and then 5-µl portions were spotted onto a Silica Gel 60 TLC plate. Substrate and products were resolved by chromatography in the system chloroform, pyridine, 88% formic acid, water (30:70:16:10, v/v). The plate was dried and exposed to a Molecular Dynamics PhosphorImager screen, which was analyzed using ImageQuant version 1.2 software for the Macintosh.
Assay for Lauroyltransferase Activity-- Assay mixtures (15 µl final volume) (8), containing 50 mM Hepes, pH 7.5, 50 mM NaCl, 5 mM MgCl2, 0.1% Triton X-100, 6 µM (Kdo)2-4'-32P-lipid IVA (80,000 cpm/nmol) and 12.5 µM lauroyl-ACP, as indicated, were preincubated at 30 °C for 10 min. Cell membranes were diluted and added to the reaction mixtures to a final protein concentration of 0.1 mg/ml. The reactions were incubated at 30 °C for 10 min at which point 5-µl portions were spotted onto a Silica Gel 60 TLC plate, which was developed and analyzed as described above for the palmitoleoyltransferase.
Cloning and Expression of the lpxP Gene Behind a T7lac Promoter-- The lpxP structural gene was obtained by PCR using pSK57 (15) as the template. Primers specific for lpxP containing an NdeI restriction site at the 5' end (5'-GCAACGGGCCATATGTTTCCACAATGCAAA-3') and an XhoI restriction site at the 3' end (5'-GCAGTCCTCGAGTTAAATGTACAACGACG-5') were used. The PCR product was digested with NdeI and XhoI and ligated into the similarly digested vector, pET 21a+ (Novagen). The resulting hybrid plasmid, pMKV2, was transformed into BLR(DE3)pLysS cells for controlled protein expression from the T7lac promoter, which is activated following T7 polymerase expression upon induction with IPTG. Overexpression and optimal enzymatic activity of LpxP was achieved by growing the plasmid-containing cells in LB broth at 37 °C to A600 of ~0.5, followed by induction with 1 mM IPTG and further incubation at 12 °C for an additional 10 h or at 37 °C for 3 h. Cell membranes from BLR(DE3)pLysS cells containing either pMKV2 or the pET21a+ vector control, grown with and without IPTG, were isolated and washed as above. The palmitoleoyltransferase assay was performed on these membranes as described above, except that the protein concentration was 0.005-0.01 mg/ml in the assay mixture, and the incubation time was reduced to 5 min at 12 °C, as indicated.
Antibiotic Minimal Inhibitory Concentrations-- Cultures were grown from an initial A600 of 0.01 in the presence of a range of antibiotic concentrations for 24 h at 30 °C or for 72 h at 12 °C. The minimal inhibitory concentration was defined as the lowest antibiotic concentration at which no measurable bacterial growth was observed. Experiments were performed in triplicate.
Isolation and Mass Spectrometry of Lipid A Samples-- Typically, 200-ml cultures were grown at 12 °C from A600 of ~0.02 to A600 = 0.5. Cells were collected by centrifugation at 5000 × g in a Beckman JA14 rotor at 4 °C and resuspended in 40 ml of phosphate buffered saline (35). Lipid A was isolated from chloroform/methanol-extracted cells by hydrolysis of the residue at 100 °C in 12.5 mM sodium acetate, pH 4.5, and 1% SDS, as described previously (36). Lipid A 1,4'-bisphosphate species were resolved on a 1-ml DEAE-cellulose column equilibrated in chloroform/methanol/water (2:3:1, v/v), which was eluted stepwise with increasing concentrations of ammonium acetate (36).
Spectra were acquired in the negative ion linear mode using a Kratos
Analytical (Manchester, UK) matrix-assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometer equipped with a 337 nm
nitrogen laser, a 20-kV extraction voltage, and time delayed extraction. Each spectrum was the average of 50 shots. The lipid A
1,4'-bisphosphate samples were prepared for MALDI/TOF analysis by
depositing 0.3 µl of the sample dissolved in chloroform/methanol (4:1
v/v), followed by 0.3 µl of the matrix, which was a mixture of
saturated 6-aza-2-thiothymine in 50% acetonitrile and 10% tribasic ammonium citrate (9:1 v/v). The sample mixtures were allowed to dry at
room temperature prior to mass analysis. Hexa-acylated lipid A
1,4'-bisphosphate from wild type E. coli (Sigma) was used as
an external standard for calibration.
| |
RESULTS |
|---|
|
|
|---|
The Effect of an lpxP Insertion Mutation on E. coli Growth at 12 °C-- MKV11 is a mutant of E. coli MC1061 in which a kanamycin gene cassette is inserted into the lpxP gene (Table I). Because palmitoleoyltransferase activity is not present in MC1061 at 30 °C (15), the insertion mutation should have no effect on viability or growth at 30 °C and above. This was verified by our ability to cure the lpxP mutant of its lpxP covering plasmid at 44 °C. However, given the fact that lpxP is induced by cold shock, it was possible that lpxP might be required for growth below 30 °C. Consequently, the growth of MKV11 at 12 °C was compared with that of MC1061. As shown in Fig. 2, the lpxP::kan strain grows at approximately the same rate as wild type E. coli at low temperatures.
|
|
Absence of Palmitoleoyltransferase Activity in the lpxP
Mutant--
Multiple copies of the plasmid pSK57 (15), which contains
a 5.6-kb segment of the E. coli genome including the
lpxP gene, direct the overproduction of
palmitoleoyltransferase activity (15). It was therefore anticipated
that a disruption of the lpxP gene would completely
eliminate palmitoleoyltransferase activity from the cell. Cultures of
MC1061 and MKV11 were grown to early log phase, and a portion of each
culture was shifted to 12 °C for 2 h. Membranes were then
isolated and assayed for palmitoleoyltransferase activity. As shown in
Fig. 3, conversion of the acceptor
substrate, (Kdo)2-4'-32P-lipid IVA,
to a more hydrophobic species representing
(Kdo)2-4'-32P-palmitoleoyl-lipid
IVA only occurred in the cold-shocked, wild type cells and
was absolutely dependent upon the inclusion of palmitoleoyl-ACP in the
reaction system. No residual palmitoleoyltransferase activity was
detected in MKV11. This finding is consistent with the proposal that
lpxP is the structural gene for the palmitoleoyltransferase. A small amount of a more rapidly migrating radioactive species (Fig. 3,
lane 6) likely arises from the action of the outer membrane enzyme PagP (37), which incorporates a palmitate chain on the hydroxymyristate residue at the 2-position of the proximal unit (Fig.
1), using endogenous glycerophospholipids as donors (38). PagP activity
is greatly induced under conditions that activate the PhoP/PhoQ
two-component signaling system (37) but not under the growth conditions
employed in the present study.
|
Normal Levels of Lauroyltransferase Activity in Membranes of
MKV11--
Lauroyltransferase activity (7, 8) was assayed in cell
membranes isolated from both MC1061 and MKV11, with and without exposure to cold shock. As shown in Fig.
4, normal amounts of lauroyltransferase
activity are present in the membranes of both strains, irrespective of
cold shock treatment. The specific activity for the transferase in all
membrane preparations is approximately the same (1.04 ± 0.11 nmol/min/mg). In addition to confirming the idea of distinct genes
encoding for the lauroyltransferases and palmitoleoyltransferases (Fig.
1), this result also shows that expression of the lauroyltransferase is
not affected by cold shock or by the absence of the
palmitoleoyltransferase.
|
Mass Spectrometry of Lipid A from Wild type E. coli and MKV11 Grown
at 12 °C--
To demonstrate the importance of the
palmitoleoyltransferase during cold shock in living cells, lipid A
1,4'-bisphosphate species were isolated from MC1061 and MKV11 grown
continuously at 12 °C to mid-log phase (A600 ~ 0.5). The hexa-acylated lipid A 1,4'-bisphosphates, purified by
chromatography on DEAE-cellulose (36), were analyzed by MALDI/TOF mass
spectrometry in the negative mode. Major peaks for lipid A from wild
type cells were observed at m/z 1851.5 and 1797.4 (Fig.
5). The larger peak at m/z
1851.5, representing about two-thirds of the total, is attributed to
[M
H]
of a cold-adapted lipid A molecule
containing a palmitoleate residue in place of laurate (Fig. 1). The
smaller peak at m/z 1797.4 represents the [M
H]
ion derived from "normal" E. coli
lipid A (Fig. 1), which contains laurate in acyloxyacyl linkage at
position-2'. The presence of the latter species in cells at 12 °C is
consistent with the in vitro assay data (Fig. 4),
demonstrating that the lauroyltransferase activity is intact in
membranes isolated from cold-shocked cells. Additional minor peaks at
m/z 1769.4 and 1824.0 (Fig. 5) likely represent lipid A
molecules lacking two methylene units, when compared with the two major
species; these probably arise from the slow incorporation of shorter
acyl chains into the acceptor (Kdo)2-lipid IVA
by the late acyltransferases (7-9).
|
Lipid A was also isolated from cold-shocked MKV11 to verify that the
palmitoleoyltransferase was not functional in vivo and to
ensure that no other modifications of the lipid A molecule were
occurring in its absence. The mass spectrometry in the negative mode
(Fig. 6) shows only a single major peak
at m/z 1797.4, which is indistinguishable from the signal
obtained with lipid A of wild type cells grown at 30 °C or above
(Fig. 1). In the absence of the palmitoleoyltransferase, the
lauroyltransferase is fully functional at 12 °C, indicating that the
two enzymes must compete for the precursor
(Kdo)2-4'-32P-lipid IVA in wild
type cells at 12 °C (Figs. 1 and 5). The absence of other major
lipid A species also confirms that no alternative modifications are
induced in the absence of LpxP. The minor peaks at m/z
1769.5 and 1825.6 (Fig. 6) are again interpreted as the loss or gain of
two methylene units due to slow incorporation of shorter or longer acyl
chains into the common precursor (Kdo)2-lipid IVA by the late acyltransferases. The absence of the peak
at m/z 1851.5 in Fig. 6 proves that the lpxP gene
product is solely responsible for palmitoleate incorporation into lipid
A in E. coli cells at low temperatures.
|
Massive Overproduction of Palmitoleoyltransferase in Cells Expressing lpxP Behind a T7lac Promoter-- The lpxP gene was cloned into a T7 polymerase expression vector, pET21a+, to confirm that controlled overproduction of the LpxP protein from a non-native promoter results in increased in vitro palmitoleoyltransferase activity. As shown in Table II, massive overproduction of palmitoleoyltransferase activity is observed only in membranes of strain BLR(DE3)pLysS cells containing the lpxP gene behind the T7lac promoter on pMKV2. The membranes from cells induced with IPTG at 12 °C have a specific activity of 44.3 × 103 pmol/min/mg, nearly 6000-fold greater than wild type, cold-shocked cells (Table II). This establishes that LpxP is necessary and sufficient for the conversion of (Kdo)2-4'-32P-lipid IVA to a more hydrophobic product in a reaction that is absolutely dependent upon the inclusion of palmitoleoyl-ACP. Interestingly, membranes from BLR(DE3)pLysS/pMKV2 that were induced with IPTG at 37 °C also overexpress LpxP activity but at a lower specific activity (Table II). These findings indicate that LpxP may not be stable when overproduced at 37 °C.
|
Antibiotic Hypersensitivity of MKV11 during Cold Shock-- As lpxP gene expression is not required for growth in liquid medium (Fig. 2) or on agar plates at 12 °C, the effect of lpxP inactivation on antibiotic resistance was determined at cold temperatures. Five antibiotics from different major structural classes were tested (Table III). Erythromycin had no effect on either strain at both temperatures at concentrations below 500 µg/ml. However, the minimal inhibitory concentrations for rifampicin and vancomycin are 10-fold less for the mutant than for the wild type at 12 °C (Table III). Bacitracin and fusidic acid also inhibited the growth of the mutant at lower concentrations than wild type during cold shock. Therefore, it is necessary for E. coli to incorporate an unsaturated fatty acid into its lipid A at low temperatures to maintain on optimal barrier for protection against harmful agents in the environment.
|
| |
DISCUSSION |
|---|
|
|
|---|
We have constructed a mutant of E. coli (MKV11) containing a kanamycin resistance cassette insertion in the structural gene of the palmitoleoyltransferase, lpxP, involved in the biosynthesis of cold-adapted lipid A (15). In contrast to its parental strain, MC1061, membranes isolated from this mutant do not convert the lipid substrate for LpxP, Kdo2-lipid IVA, to Kdo2-(palmitoleoyl)-lipid IVA (Figs. 1 and 3) and cannot incorporate any palmitoleate into its lipid A in vivo during cold shock.
The absence of the lpxP gene product does not confer any obvious growth phenotype in nutrient broth at low temperatures (Fig. 2). Furthermore, the inner and outer membranes of wild type and mutant cells do not appear to differ appreciably in their protein or lipopolysaccharide core composition, as judged by gel electrophoresis (data not shown). The ratio of glycerophospholipids to lipid A (normally about 10:1) is also not affected (data not shown). The absence of a strong phenotype associated with lpxP inactivation is a little surprising, considering that two-thirds of the lipid A species isolated from wild type E. coli cultured under cold shock conditions contain a palmitoleoyl residue (Fig. 5). It is possible that the up-regulation of unsaturated fatty acid biosynthesis and the increased incorporation of these fatty acids into the glycerophospholipids (19) during growth at low temperatures provide sufficient fluidity to maintain cell viability.
Interestingly, however, the integrity of the mutant outer membrane is altered during cold shock, as determined by antibiotic resistance studies. A 10-fold greater sensitivity to rifampicin and vancomycin verifies that incorporation of an unsaturated fatty acid during cold shock, although not required for cell survival, is essential for the maintenance of an effective outer membrane barrier. Although we favor the view that the outer membrane is leaky when the palmitoleoyl moiety is not incorporated into lipid A, we cannot entirely exclude the possibility that export of these antibiotics is compromised.
The activity of the lauroyltransferase (LpxL) (8) is not affected in
mutant cells grown at both 12 and 30 °C, confirming that the
lauroyltransferase and palmitoleoyltransferase are distinct enzymes
(Fig. 1). LpxL activity does not decrease in wild type cells upon cold
shock indicating that there must be competition between LpxL and LpxP
activity during growth at low temperatures. The composition of the
acyl-ACP pool clearly must influence the ability of these enzymes to
catalyze their respective acylation reactions at 12 °C. The increase
in activity of
-ketoacyl-ACP synthase II at cold temperatures (a
direct effect on the enzyme) (16) may result indirectly in the
diminished availability of lauroyl-ACP relative to palmitoleoyl-ACP.
In vitro, the specific activity of LpxP is at least an order
of magnitude lower than that of LpxL (15), but to date, the optimal
conditions for assaying these enzymes have not been studied in depth.
Palmitoleate is preferentially incorporated into glycerophospholipids
by 1-acyl-glycerol-3-phosphate acyltransferase (encoded by
plsC) (39), and palmitoleoyl-ACP makes up a large fraction of the acyl-ACP pool isolated from a mutant defective in glycerol 3-phosphate formation (40). Therefore, the incorporation of palmitoleate into lipid A is not limited by substrate availability at
normal growth temperatures (30 °C and above). The LpxP reaction must
be limited by the absence of enzyme protein and/or enzyme activity at
higher temperatures. It has been determined previously that the level
of lpxP mRNA at 30 °C is barely measurable but increases by several orders of magnitude following cold shock (15).
However, the induction of a T7lac promoter-driven construct of lpxP with IPTG at 37 °C yields more LpxP protein than
is seen at 12 °C (Fig. 7), but it is
less active (Table II). These findings indicate that LpxP activity may
be regulated at several levels.
|
Multiple mechanisms of regulation are seen with other cold shock proteins, including the well characterized CspA protein (41-43). The latter is an RNA-binding protein, and its expression is regulated at the level of transcription by an AT-rich upstream element (41-43). In addition CspA self-regulates at the level of translation and mRNA stability via the "cold box," a sequence upstream of the ribosome-binding site, as well as a "downstream box" within the structural gene (41-43). The 5'-untranslated regions of CspA and other cold shock proteins are unusually long, often around 150 bases, within which important sequences for regulation appear to be located (41-43). It has been determined recently that the 5'-untranslated region of the lpxP gene is 152 bases long,2 and it follows that this segment may be important for regulation. Further studies of lpxP transcription and translation are in progress.
All E. coli cold shock proteins discovered to date, with the
exception of LpxP, are involved with the maintenance of intracellular processes required for macromolecular synthesis, including replication, transcription, translation, and protein folding (41-43). The
palmitoleoyltransferase is the first protein in E. coli
specifically induced by cold shock whose activity has effects on the
outer membrane that are beneficial to the cell. The increased
incorporation of unsaturated fatty acids into a membrane structure is
termed "homeoviscous" adaptation (44, 45), and results in a
membrane containing more fatty acyl chains with lower melting
temperatures in order to maintain the appropriate fluidity. Further
characterization of the palmitoleoyltransferase, its regulation, and
the phenotype of mutant MKV11 should result in a better understanding
of this adaptation process and its importance to Gram-negative bacteria.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grants GM-51310 (to C. R. H. R.) and GM54882-01 (to R. J. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by National Institutes of Health Training Grant GM08558.
To whom correspondence should be addressed: Dept. of
Biochemistry, Duke University Medical Center, P. O. Box 3711, Durham, NC 27710. Tel.: 919-684-5326; Fax: 919-684-8885;
raetz@biochem.duke.edu.
Published, JBC Papers in Press, February 5, 2002, DOI 10.1074/jbc.M200408200
2 M. K. Vorachek-Warren and C. R. H. Raetz, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Kdo, 3-deoxy-D-manno-octulosonic acid;
IPTG, isopropyl-thio-
-D-galactoside;
MALDI/TOF, matrix-assisted laser desorption/ionization/time-of-flight;
ACP, acyl
carrier protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Raetz, C. R. H. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed), 2nd Ed., Vol. 1 , pp. 1035-1063, American Society for Microbiology, Washington, D. C. |
| 2. | Nikaido, H. (1996) in Escherichia coli and Salmonella: Cellular and Molecular Biology (Neidhardt, F. C., ed), 2nd Ed., Vol. 1 , pp. 29-47, American Society for Microbiology, Washington, D. C. |
| 3. | Brade, H., Opal, S. M., Vogel, S. N., and Morrison, D. C. (eds) (1999) Endotoxin in Health and Disease , Marcel Dekker, Inc., New York |
| 4. |
Raetz, C. R. H.
(1990)
Annu. Rev. Biochem.
59,
129-170[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Rietschel, E. T.,
Kirikae, T.,
Schade, F. U.,
Mamat, U.,
Schmidt, G.,
Loppnow, H.,
Ulmer, A. J.,
Zähringer, U.,
Seydel, U., Di,
Padova, F.,
Schreier, M.,
and Brade, H.
(1994)
FASEB J.
8,
217-225[Abstract] |
| 6. | Zähringer, U., Lindner, B., and Rietschel, E. T. (1999) in Endotoxin in Health and Disease (Brade, H. , Opal, S. M. , Vogel, S. N. , and Morrison, D. C., eds) , pp. 93-114, Marcel Dekker, Inc., New York |
| 7. |
Brozek, K. A.,
and Raetz, C. R. H.
(1990)
J. Biol. Chem.
265,
15410-15417 |
| 8. |
Clementz, T.,
Bednarski, J. J.,
and Raetz, C. R. H.
(1996)
J. Biol. Chem.
271,
12095-12102 |
| 9. |
Clementz, T.,
Zhou, Z.,
and Raetz, C. R. H.
(1997)
J. Biol. Chem.
272,
10353-10360 |
| 10. |
Karow, M.,
and Georgopoulos, C.
(1992)
J. Bacteriol.
174,
702-710 |
| 11. |
Zhou, Z.,
White, K. A.,
Polissi, A.,
Georgopoulos, C.,
and Raetz, C. R. H.
(1998)
J. Biol. Chem.
273,
12466-12475 |
| 12. |
Somerville, J. E., Jr.,
Cassiano, L.,
Bainbridge, B.,
Cunningham, M. D.,
and Darveau, R. P.
(1996)
J. Clin. Invest.
97,
359-365[Medline]
[Order article via Infotrieve] |
| 13. |
Karow, M.,
Fayet, O.,
Cegielska, A.,
Ziegelhoffer, T.,
and Georgopoulos, C.
(1991)
J. Bacteriol.
173,
741-750 |
| 14. |
Vaara, M.,
and Nurminen, M.
(1999)
Antimicrob. Agents Chemother.
43,
1459-1462 |
| 15. |
Carty, S. M.,
Sreekumar, K. R.,
and Raetz, C. R. H.
(1999)
J. Biol. Chem.
274,
9677-9685 |
| 16. |
Garwin, J. L.,
Klages, A. L.,
and Cronan, J. E., Jr.
(1980)
J. Biol. Chem.
255,
3263-3265 |
| 17. |
Aguilar, P. S.,
Cronan, J. E. J.,
and de Mendoza, D.
(1998)
J. Bacteriol.
180,
2194-2200 |
| 18. |
Aguilar, P. S.,
Hernandez-Arriaga, A. M.,
Cybulski, L. E.,
Erazo, A. C.,
and de Mendoza, D.
(2001)
EMBO J.
20,
1681-1691[CrossRef][Medline]
[Order article via Infotrieve] |
| 19. |
Morein, S.,
Andersson, A.,
Rilfors, L.,
and Lindblom, G.
(1996)
J. Biol. Chem.
271,
6801-6809 |
| 20. |
Scheidler, M. A.,
and Bell, R. M.
(1992)
Methods Enzymol.
209,
55-63[Medline]
[Order article via Infotrieve] |
| 21. |
Cronan, J. E. J.,
and Gelmann, E. P.
(1975)
Bacteriol. Rev.
39,
232-256 |
| 22. | Cronan, J. E., Jr., and Rock, C. O. (1987) in Escherichia coli and Salmonella typhimurium (Neidhardt, F. C., ed), Vol. 1 , pp. 474-497, American Society for Microbiology, Washington, D. C. |
| 23. | Miller, J. R. (1972) Experiments in Molecular Genetics , p. 433, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 24. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , pp. 1.53-1.85, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 25. |
Blattner, F. R.,
Plunkett, G.,
Bloch, C. A.,
Perna, N. T.,
Burland, V.,
Riley, M.,
Collado-Vides, J.,
Glasner, J. D.,
Rode, C. K.,
Mayhew, G. F.,
Gregor, J.,
Davis, N. W.,
Kirkpatrick, H. A.,
Goeden, M. A.,
Rose, D. J.,
Mau, B.,
and Shao, Y.
(1997)
Science
277,
1453-1474 |
| 26. |
Hamilton, C. M.,
Aldea, M.,
Washburn, B. K.,
Babitzke, P.,
and Kushner, S. R.
(1989)
J. Bacteriol.
171,
4617-4622 |
| 27. |
Garrett, T. A.,
Que, N. L.,
and Raetz, C. R. H.
(1998)
J. Biol. Chem.
273,
12457-12465 |
| 28. |
Brozek, K. A.,
Hosaka, K.,
Robertson, A. D.,
and Raetz, C. R. H.
(1989)
J. Biol. Chem.
264,
6956-6966 |
| 29. |
Basu, S. S.,
York, J. D.,
and Raetz, C. R. H.
(1999)
J. Biol. Chem.
274,
11139-11149 |
| 30. |
Jackowski, S.,
Jackson, P. D.,
and Rock, C. O.
(1994)
J. Biol. Chem.
269,
2921-2928 |
| 31. |
Sorensen, P. G.,
Lutkenhaus, J.,
Young, K.,
Eveland, S. S.,
Anderson, M. S.,
and Raetz, C. R. H.
(1996)
J. Biol. Chem.
271,
25898-25905 |
| 32. |
Rock, C. O.,
Garwin, J. L.,
and Cronan, J. E., Jr.
(1981)
Methods Enzymol.
72,
397-403[Medline]
[Order article via Infotrieve] |
| 33. |
Spencer, A. K.,
Greenspan, A. D.,
and Cronan, J. E., Jr.
(1978)
J. Biol. Chem.
253,
5922-5926 |
| 34. |
Smith, P. K.,
Krohn, R. I.,
Hermanson, G. T.,
Mallia, A. K.,
Gartner, F. H.,
Provenzano, M. D.,
Fujimoto, E. K.,
Goeke, N. M.,
Olson, B. J.,
and Klenk, D. C.
(1985)
Anal. Biochem.
150,
76-85[CrossRef][Medline]
[Order article via Infotrieve] |
| 35. |
Dulbecco, R.,
and Vogt, M.
(1954)
J. Exp. Med.
99,
167-182[Abstract] |
| 36. |
Zhou, Z.,
Lin, S.,
Cotter, R. J.,
and Raetz, C. R. H.
(1999)
J. Biol. Chem.
274,
18503-18514 |
| 37. |
Bishop, R. E.,
Gibbons, H. S.,
Guina, T.,
Trent, M. S.,
Miller, S. I.,
and Raetz, C. R. H.
(2000)
EMBO J.
19,
5071-5080[CrossRef][Medline]
[Order article via Infotrieve] |
| 38. |
Brozek, K. A.,
Bulawa, C. E.,
and Raetz, C. R. H.
(1987)
J. Biol. Chem.
262,
5170-5179 |
| 39. |
Coleman, J.
(1992)
Mol. Gen. Genet.
232,
295-303[Medline]
[Order article via Infotrieve] |
| 40. |
Rock, C. O.,
and Jackowski, S.
(1982)
J. Biol. Chem.
257,
10759-10765 |
| 41. |
Jones, P. G.,
and Inouye, M.
(1994)
Mol. Microbiol.
11,
811-818[Medline]
[Order article via Infotrieve] |
| 42. |
Thieringer, H. A.,
Jones, P. G.,
and Inouye, M.
(1998)
Bioessays
20,
49-57[CrossRef][Medline]
[Order article via Infotrieve] |
| 43. |
Yamanaka, K.,
Fang, L.,
and Inouye, M.
(1998)
Mol. Microbiol.
27,
247-255[CrossRef][Medline]
[Order article via Infotrieve] |
| 44. |
Sinensky, M.
(1974)
Proc. Natl. Acad. Sci. U. S. A.
71,
522-525 |
| 45. |
Vigh, L.,
Maresca, B.,
and Harwood, J. L.
(1998)
Trends Biochem. Sci.
23,
369-374[CrossRef][Medline]
[Order article via Infotrieve] |
| 46. |
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve] |
| 47. |
Johnston, S.,
Lee, J. H.,
and Ray, D. S.
(1985)
Gene (Amst.)
34,
137-145[CrossRef][Medline]
[Order article via Infotrieve] |
| 48. |
Crowell, D. N.,
Anderson, M. S.,
and Raetz, C. R. H.
(1986)
J. Bacteriol.
168,
152-159 |
This article has been cited by other articles:
![]() |
M. S. Trent, C. M. Stead, A. X. Tran, and J. V. Hankins Invited review: Diversity of endotoxin and its impact on pathogenesis Innate Immunity, August 1, 2006; 12(4): 205 - 223. [Abstract] [PDF] |
||||
![]() |
Y. A. Knirel, S. V. Dentovskaya, S. N. Senchenkova, R. Z. Shaikhutdinova, N. A. Kocharova, and A. P. Anisimov Review: Structural features and structural variability of the lipopolysaccharide of Yersinia pestis, the cause of plague Innate Immunity, February 1, 2006; 12(1): 3 - 9. [Abstract] [PDF] |
||||
![]() |
C. M. Reynolds, S. R. Kalb, R. J. Cotter, and C. R. H. Raetz A Phosphoethanolamine Transferase Specific for the Outer 3-Deoxy-D-manno-octulosonic Acid Residue of Escherichia coli Lipopolysaccharide: IDENTIFICATION OF THE eptB GENE AND Ca2+ HYPERSENSITIVITY OF AN eptB DELETION MUTANT J. Biol. Chem., June 3, 2005; 280(22): 21202 - 21211. [Abstract] [Full Text] [PDF] |
||||